Cases 1 - 10 of 20
Takeda Pharmaceuticals America, Inc. et al v. UCB Biopharma SPRL et al
as 3:2018cv00078
Plaintiff:
Takeda Pharmaceuticals America, Inc. , Takeda Pharmaceuticals U.S.A., Inc. and Millennium Pharmaceuticals, Inc.
Defendant:
UCB Biopharma SPRL, Celltech R&D Limited and UCB Celltech
Cause Of Action: 35 U.S.C. § 281
Ariad Pharmaceuticals, Inc. v. Matal
as 1:2017cv00733
Plaintiff:
Ariad Pharmaceuticals, Inc.
Defendant:
Joseph Matal
Cause Of Action: 35 U.S.C. § 154
Supernus Pharmaceuticals, Inc. et al v. Lee
as 1:2016cv00342
Plaintiff:
Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation
Defendant:
Michelle K. Lee
Cause Of Action: 35 U.S.C. § 154
University of Western Australia et al v. Academisch Ziekenhuis Leiden et al
as 1:2016cv00204
Plaintiff:
University of Western Australia , Sarepta Therapeutics, Inc. and Sarepta International C.V.
Defendant:
Academisch Ziekenhuis Leiden , Biomarin Pharmaceutical, Inc. and Biomarin Nederland B.V.
Cause Of Action: 35 U.S.C. § 146
Eli Lilly and Company et al v. Lupin Pharmaceuticals, Inc. et al
as 1:2015cv00877
Plaintiff:
Eli Lilly and Company , Eli Lilly Exports S.A. and Acrux DDS Pty Ltd.
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Cause Of Action: 35 U.S.C. § 271
Kremers Urban Pharmaceuticals, Inc. v. Rea et al
as 3:2013cv00399
Plaintiff:
Kremers Urban Pharmaceuticals, Inc.
Defendant:
Teresa Stanek Rea and United States Patent and Trademark Office
Cause Of Action: 05 U.S.C. § 0706 Judicial Review of Agency Action
G.D. Searle LLC et al v. Lupin Pharmaceuticals, Inc. et al
as 2:2013cv00121
Plaintiff:
G.D. Searle LLC and Pfizer Asia Pacific PTE, LTD.
Defendant:
Lupin Pharmaceuticals, Inc. , Teva Pharmaceuticals USA, Inc. , Mylan Pharmaceuticals Inc. and others
Counter_claimant:
Watson Laboratories, Inc. and Lupin Pharmaceuticals, Inc.
Counter_defendant:
G.D. Searle LLC and Pfizer Asia Pacific PTE, LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Transcept Pharmaceuticals, Inc. v. Kappos
as 1:2013cv00019
Plaintiff:
Transcept Pharmaceuticals, Inc.
Defendant:
Hon. David J. Kappos
Cause Of Action: 35 U.S.C. § 154 AIA Appeal of Patent Term Adjustment Determination
Noven Pharmaceuticals, Inc. v. Kappos
as 1:2013cv00017
Plaintiff:
Noven Pharmaceuticals, Inc.
Defendant:
David J. Kappos
Cause Of Action: 35 U.S.C. § 154 AIA Appeal of Patent Term Adjustment Determination
Millennium Pharmaceuticals, Inc. v. Kappos
as 1:2012cv01479
Plaintiff:
Millennium Pharmaceuticals, Inc.
Defendant:
David J. Kappos
Cause Of Action: 35 U.S.C. § 154 AIA Appeal of Patent Term Adjustment Determination
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
